share_log

12 Health Care Stocks Moving In Friday's After-Market Session

Benzinga ·  Mar 16 05:33

Gainers

  • Cue Health (NASDAQ:HLTH) shares increased by 12.1% to $0.22 during Friday's after-market session. The company's market cap stands at $34.8 million. As per the press release, Q4 earnings came out 2 days ago.
  • Aclarion (NASDAQ:ACON) shares increased by 10.39% to $0.44. The market value of their outstanding shares is at $3.1 million.
  • BioSig Technologies (NASDAQ:BSGM) shares increased by 9.39% to $0.58. The market value of their outstanding shares is at $5.4 million.
  • OptiNose (NASDAQ:OPTN) stock increased by 9.09% to $2.04. The company's market cap stands at $229.8 million.
  • SCWorx (NASDAQ:WORX) stock rose 7.55% to $1.85. The market value of their outstanding shares is at $2.2 million.
  • Avenue Therapeutics (NASDAQ:ATXI) shares moved upwards by 7.3% to $0.17. The market value of their outstanding shares is at $6.3 million.

Losers

  • Molecular Templates (NASDAQ:MTEM) shares declined by 12.7% to $2.4 during Friday's after-market session. The company's market cap stands at $12.8 million.
  • Better Therapeutics (NASDAQ:BTTX) shares declined by 7.4% to $0.04. The company's market cap stands at $2.2 million.
  • PaxMedica (NASDAQ:PXMD) stock fell 6.28% to $0.7. The market value of their outstanding shares is at $5.1 million.
  • Aligos Therapeutics (NASDAQ:ALGS) shares declined by 5.26% to $0.9. The market value of their outstanding shares is at $68.1 million. As per the news, the Q4 earnings report came out 3 days ago.
  • Autolus Therapeutics (NASDAQ:AUTL) shares fell 4.99% to $5.53. The market value of their outstanding shares is at $1.2 billion. As per the press release, Q4 earnings came out yesterday.
  • Mersana Therapeutics (NASDAQ:MRSN) stock decreased by 4.97% to $4.79. The market value of their outstanding shares is at $581.0 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment